NCT06531850|Unknown
Loading search results
Sponsor study identifier
observational
200
1 country
1
Study Start
January 1, 2024
Actual (reported)Primary Completion
January 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Based on previous studies, this project intends to use prospective studies to select patients identified by imaging as pulmonary nodules to explore the potential of RP5-977B1 in differentiating benign and malignant pulmonary nodules, construct diagnostic models combined with clinical protein tumor markers, compare the diagnostic efficacy of the two, and finally determine the sensitivity and specificity of markers through pathological results. It provides a new content for the diagnosis of benign and malignant pulmonary nodules.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2024
Actual (reported)July 29, 2024
Actual (reported)August 1, 2024
Actual (reported)January 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
January 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Benign nodule
Pathological findings determined that the nodules were benign in the patient
A week
Tumor
Pathological findings identified the nodules as malignant tumors in the patient
A week
* Pulmonary nodules were detected by imaging and surgically resected. * Age 15-75 years old. * Surgery or puncture is to be performed for pathological diagnosis. ④ Adequate hematological function and liver and kidney function reserve. ⑤ The sample has no hemolysis, sufficient margin, and the source record is clear and can be checked.
* Pulmonary nodules were detected by imaging and surgically resected. * Age 15-75 years old. * Surgery or puncture is to be performed for pathological diagnosis. ④ Adequate hematological function and liver and kidney function reserve. ⑤ The sample has no hemolysis, sufficient margin, and the source record is clear and can be checked.
Serum samples from patients with radiographic findings and surgical removal of pulmonary nodules were selected.
Cancer Hospital & Affiliated Guangzhou Medical University
Guangzhou, Guangdong, 510095, China
Zijian Wu, Learned
Cancer Hospital & Affiliated Guangzhou Medical University
First Submitted
July 29, 2024
First Posted
August 1, 2024
Study Start
January 1, 2024
Actual (reported)Primary Completion
January 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Puncture Template Assisted Biopsy for Pulmonary Nodules
Video Double-Lumen Tube for Secondary Pulmonary Resection
Contact the study team to confirm eligibility.
Study Completion
January 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 1, 2024
Record last verified: 2024-01
Due to the requirements of the institution and the need to protect the privacy of patients, it is not convenient to disclose IPD.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: